Body Composition Predicts Immunotherapy Success in Lung Cancer Patients

A new study shows that a cancer patient's muscle and fat distribution significantly affects how well checkpoint inhibitor drugs work against advanced lung cancer. The finding could help oncologists predict treatment response before starting expensive therapy, potentially improving outcomes while reducing costs for health systems and insurers.

Originaltitel: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors